|
1
|
Squadroni M, Tondulli L, Gatta G, Mosconi
S, Beretta G and Labianca R: Cholangiocarcinoma. Crit Rev Oncol
Hematol. 116:11–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blechacz B: Cholangiocarcinoma: Current
knowledge and new developments. Gut Liver. 11:13–26. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saha SK, Zhu AX, Fuchs CS and Brooks GA:
Forty-year trends in cholangiocarcinoma Incidence in the U.S:
Intrahepatic disease on the rise. Oncologist. 21:594–599. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fairweather M, Balachandran VP and
D'Angelica MI: Surgical management of biliary tract cancers. Chin
Clin Oncol. 5:632016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghouri YA, Mian I and Blechacz B: Cancer
review: Cholangiocarcinoma. J Carcinog. 14:12015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu J, Zhao J and Zhang R: Four microRNAs
signature for survival prognosis in colon cancer using TCGA Data.
Sci Rep. 6:383062016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ge YZ, Wu R, Xin H, Zhu M, Lu TZ, Liu H,
Xu Z, Yu P, Zhao YC, Li MH, et al: A tumor-specific microRNA
signature predicts survival in clear cell renal cell carcinoma. J
Cancer Res Clin Oncol. 141:1291–1299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang B, Li Y and Wang T: A three miRNAs
signature predicts survival in cervical cancer using bioinformatics
analysis. Sci Rep. 7:56242017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Puik JR, Meijer LL, Le Large TY, Prado MM,
Frampton AE, Kazemier G and Giovannetti E: miRNA profiling for
diagnosis, prognosis and stratification of cancer treatment in
cholangiocarcinoma. Pharmacogenomics. 18:1343–1358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu HT and Gao P: The roles of microRNAs
related with progression and metastasis in human cancers. Tumour
Biol. 2016.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandran UR, Medvedeva OP, Barmada MM,
Blood PD, Chakka A, Luthra S, Ferreira A, Wong KF, Lee AV, Zhang Z,
et al: TCGA Expedition: A data acquisition and management system
for TCGA Data. PLoS One. 11:e01653952016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang MY, Li SH, Huang GL, Lin GH, Shuang
ZY, Lao XM, Xu L, Lin XJ, Wang HY and Li SP: Identification of a
novel microRNA signature associated with intrahepatic
cholangiocarcinoma (ICC) patient prognosis. BMC Cancer. 15:642015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Varkonyi-Gasic E, Wu R, Wood M, Walton EF
and Hellens RP: Protocol: A highly sensitive RT-PCR method for
detection and quantification of microRNAs. Plant Methods. 3:122007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Q, Tang H, Yin S and Dong C:
Downregulation of microRNA-138 enhances the proliferation,
migration and invasion of cholangiocarcinoma cells through the
upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep. 29:2046–2052.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu L, Huang F, Deng G, Nie W, Huang W, Xu
H, Zheng S, Yi Z and Wan T: MicroRNA-212 targets FOXA1 and
suppresses the proliferation and invasion of intrahepatic
cholangiocarcinoma cells. Exp Ther Med. 13:21092017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamanaka S, Campbell NR, An F, Kuo SC,
Potter JJ, Mezey E, Maitra A and Selaru FM: Coordinated effects of
microRNA-494 induce G2/M arrest in human cholangiocarcinoma. Cell
Cycle. 11:2729–2738. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N, Jiang F, He TL, Zhang JK, Zhao J,
Wang C, Jiang GX, Cao LP, Kang PC, Zhong XY, et al: The Roles of
MicroRNA-122 overexpression in inhibiting proliferation and
invasion and stimulating apoptosis of human cholangiocarcinoma
cells. Sci Rep. 5:165662015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McNally ME, Collins A, Wojcik SE, Liu J,
Henry JC, Jiang J, Schmittgen T and Bloomston M: Concomitant
dysregulation of microRNAs miR-151-3p and miR-126 correlates with
improved survival in resected cholangiocarcinoma. HPB (Oxford).
15:260–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Silakit R, Loilome W, Yongvanit P, Chusorn
P, Techasen A, Boonmars T, Khuntikeo N, Chamadol N, Pairojkul C and
Namwat N: Circulating miR-192 in liver fluke-associated
cholangiocarcinoma patients: A prospective prognostic indicator. J
Hepatobiliary Pancreat Sci. 21:864–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang LJ, Zhang KL, Zhang N, Ma XW, Yan SW,
Cao DH and Shi SJ: Serum miR-26a as a diagnostic and prognostic
biomarker in cholangiocarcinoma. Oncotarget. 6:18631–18640.
2015.PubMed/NCBI
|
|
27
|
Li J, Gao B, Huang Z, Duan T, Li D, Zhang
S, Zhao Y, Liu L, Wang Q, Chen Z and Cheng K: Prognostic
significance of microRNA-203 in cholangiocarcinoma. Int J Clin Exp
Pathol. 8:9512–9516. 2015.PubMed/NCBI
|
|
28
|
Cheng Q, Feng F, Zhu L, Zheng Y, Luo X,
Liu C, Yi B and Jiang X: Circulating miR-106a is a novel prognostic
and lymph node metastasis indicator for cholangiocarcinoma. Sci
Rep. 5:161032015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng Y and Chen Y: Increased expression of
miR-29a and its prognostic significance in patients with
cholangiocarcinoma. Oncol Res Treat. 40:128–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du F, Yuan P, Zhao ZT, Yang Z, Wang T,
Zhao JD, Luo Y, Ma F, Wang JY, Fan Y, et al: A miRNA-based
signature predicts development of disease recurrence in HER2
positive breast cancer after adjuvant trastuzumab-based treatment.
Sci Rep. 6:338252016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fkih M, 'hamed I, Privat M, Ponelle F,
Penault-Llorca F, Kenani A and Bignon YJ: Identification of
miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative
breast cancer biomarkers. Cell Oncol. 38:433–442. 2015. View Article : Google Scholar
|
|
33
|
Huang L, Lin JX, Yu YH, Zhang MY, Wang HY
and Zheng M: Downregulation of six microRNAs is associated with
advanced stage, lymph node metastasis and poor prognosis in small
cell carcinoma of the cervix. PLoS One. 7:e337622012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Li Y, Ding M, Zhang H, Xu X and
Tang J: Molecular mechanisms and clinical applications of miR-22 in
regulating malignant progression in human cancer (Review). Int J
Oncol. 50:345–355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu D, Takeshita F, Hino Y, Fukunaga S,
Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A,
et al: miR-22 represses cancer progression by inducing cellular
senescence. J Cell Biol. 193:409–424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Budd WT, Seashols-Williams SJ, Clark GC,
Weaver D, Calvert V, Petricoin E, Dragoescu EA, O'Hanlon K and
Zehner ZE: Dual action of miR-125b as a tumor suppressor and
OncomiR-22 promotes prostate cancer tumorigenesis. PLoS One.
10:e01423732015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng
HX, Hu XX and Wang SK: MicroRNA expression profiles predict
progression and clinical outcome in lung adenocarcinoma. Onco
Targets Ther. 9:5679–5692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song G, Zhang H, Chen C, Gong L, Chen B,
Zhao S, Shi J, Xu J and Ye Z: miR-551b regulates
epithelial-mesenchymal transition and metastasis of gastric cancer
by inhibiting ERBB4 expression. Oncotarget. 8:45725–45735.
2017.PubMed/NCBI
|
|
39
|
Yuan H, Chen Z, Bai S, Wei H, Wang Y, Ji
R, Guo Q, Li Q, Ye Y, Wu J, et al: Molecular mechanisms of lncRNA
SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. Cancer Lett.
418:84–96. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ewald F, Norz D, Grottke A, Hofmann BT,
Nashan B and Jucker M: Dual inhibition of PI3K-AKT-mTOR- and
RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and
reverses acquired resistance to MEK-inhibitors. Invest New Drugs.
32:1144–1154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guan L, Zhang L, Gong Z, Hou X, Xu Y, Feng
X, Wang H and You H: FoxO3 inactivation promotes human
cholangiocarcinoma tumorigenesis and chemoresistance through
Keap1-Nrf2 signaling. Hepatology. 63:1914–1927. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thongchot S, Yongvanit P, Loilome W,
Seubwai W, Phunicom K, Tassaneeyakul W, Pairojkul C, Promkotra W,
Techasen A and Namwat N: High expression of HIF-1alpha, BNIP3 and
PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma
survival and metastasis. Asian Pac J Cancer Prev. 15:5873–5878.
2014. View Article : Google Scholar : PubMed/NCBI
|
